Michelle Skelton

965 total citations
33 papers, 638 citations indexed

About

Michelle Skelton is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Michelle Skelton has authored 33 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Michelle Skelton's work include HIV/AIDS drug development and treatment (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and HIV Research and Treatment (4 papers). Michelle Skelton is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and HIV Research and Treatment (4 papers). Michelle Skelton collaborates with scholars based in South Africa, United States and United Kingdom. Michelle Skelton's co-authors include Collet Dandara, William Paul Skelton, Ambroise Wonkam, Marelize Swart, Nicola Mulder, David L. Vesely, Peter J. Smith, Nicholas Ekow Thomford, Kevin Dzobo and Alice Matimba and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cellular and Molecular Life Sciences.

In The Last Decade

Michelle Skelton

31 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Skelton South Africa 13 202 120 93 92 77 33 638
Steven Watterson United Kingdom 13 297 1.5× 46 0.4× 36 0.4× 44 0.5× 45 0.6× 28 842
Hsinyi Tsang United States 15 176 0.9× 167 1.4× 42 0.5× 33 0.4× 36 0.5× 29 596
John E. Burkhardt United States 15 243 1.2× 76 0.6× 64 0.7× 76 0.8× 123 1.6× 38 1.1k
Pennelope Blakely United States 13 98 0.5× 96 0.8× 99 1.1× 19 0.2× 46 0.6× 26 530
Olga N. Ivanova Russia 13 380 1.9× 139 1.2× 29 0.3× 37 0.4× 51 0.7× 38 973
Manuela Del Cornò Italy 21 254 1.3× 80 0.7× 24 0.3× 31 0.3× 162 2.1× 36 1.0k
Xiaolei Hu China 20 299 1.5× 35 0.3× 20 0.2× 98 1.1× 90 1.2× 48 929
Beata Orzechowska Poland 13 226 1.1× 47 0.4× 27 0.3× 42 0.5× 83 1.1× 35 580
Liran Xu China 12 161 0.8× 81 0.7× 43 0.5× 24 0.3× 19 0.2× 48 403

Countries citing papers authored by Michelle Skelton

Since Specialization
Citations

This map shows the geographic impact of Michelle Skelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Skelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Skelton more than expected).

Fields of papers citing papers by Michelle Skelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Skelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Skelton. The network helps show where Michelle Skelton may publish in the future.

Co-authorship network of co-authors of Michelle Skelton

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Skelton. A scholar is included among the top collaborators of Michelle Skelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Skelton. Michelle Skelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Agamah, Francis E., Thomas H. A. Ederveen, Michelle Skelton, et al.. (2024). Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases. 1(1).
3.
Agamah, Francis E., Thomas H. A. Ederveen, Michelle Skelton, et al.. (2024). Network-based integrative multi-omics approach reveals biosignatures specific to COVID-19 disease phases. Frontiers in Molecular Biosciences. 11. 1393240–1393240. 2 indexed citations
4.
Skelton, Michelle, et al.. (2024). Men with HIV have increased alveolar bone loss. BMC Oral Health. 24(1). 1248–1248. 2 indexed citations
5.
Agamah, Francis E., Cornelius Ewuoso, Ebony Madden, et al.. (2023). Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities. Journal of Medical Ethics. 50(1). 57–61. 1 indexed citations
6.
Nembaware, Victoria, Anne Priest, Michelle Skelton, et al.. (2022). Competency-based Training Needs Assessment for Research Managers and Administrators in Africa and the United Kingdom to Strengthen Equitable Partnerships. SHILAP Revista de lepidopterología. 5. 11–11. 3 indexed citations
7.
Agamah, Francis E., et al.. (2021). Network-driven analysis of human–Plasmodium falciparum interactome: processes for malaria drug discovery and extracting in silico targets. Malaria Journal. 20(1). 421–421. 8 indexed citations
8.
Skelton, Michelle, et al.. (2018). Electrocardiographic artifact potentially misleading to the wrong management. Annals of Translational Medicine. 6(1). 17–17. 4 indexed citations
9.
Mulder, Nicola, Alash’le Abimiku, Sally N. Adebamowo, et al.. (2018). H3Africa: current perspectives. Pharmacogenomics and Personalized Medicine. Volume 11. 59–66. 114 indexed citations
10.
Kampira, Elizabeth, Sandra Castel, Lubbe Wiesner, et al.. (2016). Differences in Genetic Variants in Lopinavir Disposition Among Hiv-Infected Bantu Africans. Pharmacogenomics. 17(7). 679–690. 11 indexed citations
11.
Thomford, Nicholas Ekow, Kevin Dzobo, Denis Chopera, et al.. (2015). Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition. Pharmaceuticals. 8(3). 637–663. 73 indexed citations
12.
Swart, Marelize, Michelle Skelton, Yuan Ren, et al.. (2013). High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients. Pharmacogenetics and Genomics. 23(8). 415–427. 58 indexed citations
13.
Skelton, William Paul, Michelle Skelton, & David L. Vesely. (2012). Cardiac hormones are potent inhibitors of secreted frizzled-related protein-3 in human cancer cells. Experimental and Therapeutic Medicine. 5(2). 475–478. 11 indexed citations
14.
Swart, Marelize, et al.. (2012). CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics. Current pharmacogenomics and personalized medicine (Online). 10(1). 43–53. 26 indexed citations
15.
Nguyen, Jennifer, et al.. (2012). Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones. Molecular and Cellular Biochemistry. 371(1-2). 209–215. 9 indexed citations
16.
Skelton, Michelle, Michael C. Kew, & Anna Kramvis. (2011). Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. Virus Research. 163(1). 59–65. 4 indexed citations
17.
Smuts, Heidi, Anna Kramvis, Michelle Skelton, et al.. (2004). Molecular Characterization of Duck Hepatitis B Virus Isolates from South African Ducks. Virus Genes. 28(2). 179–186. 11 indexed citations
18.
Kedda, Mary-Anne, Michael C. Kew, Michelle Skelton, & John Hodkinson. (1998). Non‐specificity of messenger RNA of α‐fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans. Journal of Gastroenterology and Hepatology. 13(9). 885–891. 3 indexed citations
19.
Skelton, Michelle, M C Kew, M C Yu, et al.. (1997). Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans?. Hepatology. 26(3). 740–742. 31 indexed citations
20.
Skelton, Michelle, A. Alevizos, & J. Koester. (1992). Control of the cardiovascular system ofAplysia by identified neurons. Cellular and Molecular Life Sciences. 48(9). 809–817. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Watterson Breakdown of academic impact, for papers by Hsinyi Tsang Breakdown of academic impact, for papers by John E. Burkhardt Breakdown of academic impact, for papers by Pennelope Blakely Breakdown of academic impact, for papers by Olga N. Ivanova Breakdown of academic impact, for papers by Manuela Del Cornò Breakdown of academic impact, for papers by Xiaolei Hu Breakdown of academic impact, for papers by Beata Orzechowska Breakdown of academic impact, for papers by Liran Xu
Rankless by CCL
2026